SCHEDULE 13G

Company

CITIUS ONCOLOGY, INC.

Filed

October 20, 2022

Accession Number

0001376474-22-000427

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →